Severe complications from semaglutide remain uncommon, with fewer than 4 emergency department visits per 1,000 patients reported in a Harvard-CDC study
Key Takeaways FDA-approved for T2D: Ozempic was approved for type 2 diabetes in December 2017
Reduced body weight, lipids, blood pressure, inflammatory markers, oxidative stress, endothelial dysfunction, and subclinical atherosclerosis
It retains the full anti-inflammatory power of the parent hormone without causing skin tanning
To enhance the accuracy and reliability of our study, it is imperative to include more studies in future analyses to ensure more comprehensive and unbiased results
Semaglutida 2,4 mg no debe usarse en combinacin con otros productos que contengan semaglutida, otros agonistas del receptor de GLP-1 u otros productos destinados a la prdida de peso, incluidos medicamentos recetados, medicamentos de venta libre y productos herbales, segn el comunicado